Capital Expenditures - AVROBIO Inc (NASDAQ:TECX) - Alpha Spread

AVROBIO Inc
NASDAQ:TECX

Watchlist Manager
AVROBIO Inc Logo
AVROBIO Inc
NASDAQ:TECX
Watchlist
Price: 19.14 USD 0.74%
Market Cap: 281.9m USD
Have any thoughts about
AVROBIO Inc?
Write Note

AVROBIO Inc
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

AVROBIO Inc
Capital Expenditures Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
AVROBIO Inc
NASDAQ:TECX
Capital Expenditures
-$8k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Capital Expenditures
-$858m
CAGR 3-Years
1%
CAGR 5-Years
-6%
CAGR 10-Years
-4%
Gilead Sciences Inc
NASDAQ:GILD
Capital Expenditures
-$572m
CAGR 3-Years
3%
CAGR 5-Years
7%
CAGR 10-Years
-5%
Amgen Inc
NASDAQ:AMGN
Capital Expenditures
-$965m
CAGR 3-Years
-14%
CAGR 5-Years
-8%
CAGR 10-Years
-3%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Capital Expenditures
-$481.8m
CAGR 3-Years
-12%
CAGR 5-Years
-47%
CAGR 10-Years
-23%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Capital Expenditures
-$886.1m
CAGR 3-Years
-15%
CAGR 5-Years
-20%
CAGR 10-Years
-14%

See Also

What is AVROBIO Inc's Capital Expenditures?
Capital Expenditures
-8k USD

Based on the financial report for Dec 31, 2023, AVROBIO Inc's Capital Expenditures amounts to -8k USD.

What is AVROBIO Inc's Capital Expenditures growth rate?
Capital Expenditures CAGR 1Y
97%

Over the last year, the Capital Expenditures growth was 97%.

Back to Top